Dose-dependent effect of α-tocopherol on activity of xenobiotic metabolizing enzymes in rat liver

Bulletin of Experimental Biology and Medicine

Volumn 136, Issue 1, 2003, Pages 38-41

  Sidorova, Yu A ^a   Ivanova, E V ^a   Grishanova, A Yu ^a   Lyakhovich, V V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

Author keywords

tocopherol; CYP1A; CYP2B; CYP2C; Glutathione S transferase; NADPH cytochrome P450 reductase

Indexed keywords

7 BENZYLOXYRESORUFIN O DEALKYLASE; 7 METHOXYRESORUFIN O DEALKYLASE; ALPHA TOCOPHEROL; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2C; CYTOSOL RECEPTOR; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; PENTOXYRESORUFIN DEALKYLASE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; TOCOPHEROL DERIVATIVE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CATALYSIS; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG EFFECT; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME METABOLISM; MALE; NONHUMAN; RAT; STARVATION;

ALPHA-TOCOPHEROL; ANIMALS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE TRANSFERASE; LIVER; MALE; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; RATS, WISTAR; XENOBIOTICS;

ANIMALIA;

EID: 0347269019     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026080611490     Document Type: Article

References (14)

1. M. D. Burke, S. Thompson, C. R. Elcombe, et al., Biochem. Pharmacol., 34, 3337-3345 (1985).
2. H. W. Chen, C. K. Lii, W. C. Sung, and Y. Ko, J. Nutr. Cancer, 31, 178-183 (1998).
3. W. H. Habig, M.J. Pabst, and W. B. Jakoby, J. Biol. Chem., 249, No. 22, 7130-7139 (1974).
4. L. G. Hansen and W. J. Warwick, Clin. Biochem., 3, 225-229 (1970).
5. P. Honkakoski and M. Negishi, Biochem. J., 347, Pt. 2, 321-337 (2000).
6. M. Iwasaki, M. Iwama, N. Miyata, et al., Int. J. Vitam. Nutr. Res., 64, 109-112 (1994).
7. N. Landes, P. Pfluger, D. Kluth, Biochem. Pharmacol., 65, 269-273 (2003).
8. J. M. Maglich, C. M. Stoltz, B. Goodwin, et al., Xenobiotica, 32, 451-478 (2002).
9. M. Murray, Biochem. Pharmacol., 42, 2107-2114 (1991).
10. T. Omura, and R. Sato, J. Biol. Chem., 239, 2370-2385 (1964).
11. A. H. Phillips and R. G Langdon, Ibid., 237, 2652-2660 (1962).
12. R. Ricciarelli, J.-M. Zingg, and A. Azzi, FAZEB J., 15, 2314-2325 (2001).
13. E. G. Schuetz, Curr. Drug. Metab., 2, 139-147 (2001).
14. S. J. Stohs, M. Q. Hassan, and W. J. Murray, Xenobiotica, 14, 533-537 (1984).